A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

NCT00606697 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: GR205171
DRUG: GW597599

Sponsor

GlaxoSmithKline